Nick has a background in translational biomedical research and nanomaterials development. He is a Senior Lecturer in the School of Medical Science at the University of Sydney and a research leader at the ANZAC Research Institute, where his work focuses on nanotechnologies for clinical application, including drug, biologic, and gene therapy delivery.
Nick is Co‑Founder and CEO of Endo Axiom, leading the translation of these technologies toward clinical trials. His research has been supported by the NHMRC, MRFF, and the University of Sydney.
.png)
